Download PDF
Geburtshilfe Frauenheilkd 2013; 73(8): 760-764
DOI: 10.1055/s-0033-1350706
Aktuell diskutiert
Georg Thieme Verlag KG Stuttgart · New York

Endokrinologie. Alternative Therapiemöglichkeiten zur Hormontherapie – Teil 2: pflanzliche Therapien, nicht hormonale Therapien und mehr

Dolores Foth
Further Information

Publication History

Publication Date:
27 August 2013 (online)

Also available at
    Permissions and Reprints

Alternative Therapiemöglichkeiten klimakterischer Beschwerden umfassen Nahrungsergänzungsmittel, nicht rezeptpflichtige, überwiegend pflanzliche Präparate und nicht hormonale Therapien mit Arzneimitteln anderer Indikationsbereiche. Präparate, die Cimicifuga racemosa oder Phytoestrogene beinhalten, werden am häufigsten eingesetzt. Zu diesen Präparaten liegen heute auch die meisten wissenschaftlichen Untersuchungen vor.

Weitere Literatur als PDF

 

  • Literatur

  • 1 Borelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: A systemic review of its efficacy. Pharmacol Res 2008; 58: 8-14
    CrossrefPubMedGoogle Scholar
  • 2 Kraft K. Cimicifuga, Johanniskraut und andere Phytotherapeutika im Klimakterium. Gynäkologische Endokrinologie 2008; 6: 72-75
    CrossrefPubMedGoogle Scholar
  • 3 Walji R, Boon H, Guns E et al. Black cohosh (Cimicifuga racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support Care Cancer 2007; 15: 913-921
    CrossrefPubMedGoogle Scholar
  • 4 Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database Syst Rev 2012; (9) CD007244
    PubMedGoogle Scholar
  • 5 Palacio C, Masri G, Mooradian AD. Black cohosh for the management of menopausal symptoms: a systematic review of clinical trials. Drugs Aging 2009; 26: 23-36
    CrossrefPubMedGoogle Scholar
  • 6 Cheema D, Coomarasamy A, El-Toukhy T. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review. Arch Gynecol Obstet 2007; 276: 463-469
    CrossrefPubMedGoogle Scholar
  • 7 Geller SE, Studee L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Womens Health 2005; 14: 634-649
    CrossrefPubMedGoogle Scholar
  • 8 Huntley AL, Ernst E. A systematic review of the safety of black cohosh. Menopause 2003; 10: 58-64
    CrossrefPubMedGoogle Scholar
  • 9 Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomised, controlled trials. Ann Int Med 2002; 137: 805-813
    CrossrefPubMedGoogle Scholar
  • 10 Newton KM, Reed SD, LaCroix AZ et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Ann Intern Med 2006; 145: 869-879
    CrossrefPubMedGoogle Scholar
  • 11 Briese V, Stammwitz U, Friede M et al. Black cohosh with or without St. Johnʼs wort for symptom-specific climacteric treatment – results of a large-scale, controlled, observational study. Maturitas 2007; 57: 405-414
    CrossrefPubMedGoogle Scholar
  • 12 Laakmann E, Grajecki D, Doege K et al. Efficacy of Cimicifuga racemosa, Hypericum perforatum and Agnus castus in the treatment of climacteric complaints: a systematic review. Gynecol Endocrinol 2012; 28: 703-709
    CrossrefPubMedGoogle Scholar
  • 13 Hirschberg AL, Edlund M, Svane G et al. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Menopause 2007; 14: 89-96
    CrossrefPubMedGoogle Scholar
  • 14 Raus K, Brucker C, Gorkow C et al. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Menopause 2006; 13: 678-691
    CrossrefPubMedGoogle Scholar
  • 15 Rebbeck TR, Troxel AB, Norman S et al. A retrospective case-control study of the use of hormone-related supplements and association with breast cancer. Int J Cancer 2007; 120: 1523-1528
    CrossrefPubMedGoogle Scholar
  • 16 Zepelin HH, Meden H, Kostev K et al. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol 2007; 45: 143-154
    PubMedGoogle Scholar
  • 17 Community herbal monograph on Cimicifuga racemosa (L.) Nutt., rhizoma, EMA/HMPC/600717/2007 Corr, 2010.
    PubMedGoogle Scholar
  • 18 Reed SD, Newton KM, LaCroix AZ et al. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) study. Menopause 2008; 15: 51-58
    PubMedGoogle Scholar
  • 19 Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008; 199: 455-466
    CrossrefPubMedGoogle Scholar
  • 20 Mahady GB, Low Dog T, Barrett ML et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15 (4 Pt 1) 628-638
    CrossrefPubMedGoogle Scholar
  • 21 Heger M, Ventskovskiy BM, Borzenko I et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial. Menopause 2006; 13: 744
    CrossrefPubMedGoogle Scholar
  • 22 Wober J, Möller F, Richter T et al. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol 2007; 107: 191-201
    CrossrefPubMedGoogle Scholar
  • 23 Hasper I, Ventskovskiy BM, Rettenberger R et al. Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms. Menopause 2009; 16: 117-131
    CrossrefPubMedGoogle Scholar
  • 24 NAMS. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004; 11: 11-33
    CrossrefPubMedGoogle Scholar
  • 25 Wong VC, Lim CE, Luo X et al. Current alternative and complementary therapies used in menopause. Gynecol Endocrinol 2009; 25: 166-174
    CrossrefPubMedGoogle Scholar
  • 26 Winther K, Rein E, Hedman C. Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climacteric 2005; 8: 162-170
    CrossrefPubMedGoogle Scholar
  • 27 Nedrow A, Miller J, Walker M et al. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006; 166: 1453-1465
    CrossrefPubMedGoogle Scholar
  • 28 Ziaei S, Kazemnejad A, Zareai M. The effect of vitamin E on hot flashes in menopausal women. Gynecol Obstet Invest 2007; 64: 204-207
    CrossrefPubMedGoogle Scholar
  • 29 Pachman DR, Jones JM, Loprinzi JL. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health 2010; 2: 123-135
    PubMedGoogle Scholar
  • 30 Pitkin J. Alternative and complementary therapies for the menopause. Menopause Int 2012; 18: 20-27
    CrossrefPubMedGoogle Scholar
  • 31 Loprinzi CL, Pisansky TM, Fonseca R et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol 1998; 16: 2377-2381
    PubMedGoogle Scholar
  • 32 Loprinzi CL, Kugler JW, Sloan JA et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 2000; 356: 2059-2063
    CrossrefPubMedGoogle Scholar
  • 33 Evans ML, Pritts E, Vittinghoff E et al. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005; 105: 161-166
    CrossrefPubMedGoogle Scholar
  • 34 Stearns V, Slack R, Greep N et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005; 23: 6919-6930
    CrossrefPubMedGoogle Scholar
  • 35 Loprinzi CL, Sloan JA, Perez EA et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol 2002; 20: 1578-1583
    CrossrefPubMedGoogle Scholar
  • 36 Barton DL, Loprinzi CL, Novotny P et al. Pilot evaluation of Citalopram for the relief of hot flashes. J Support Oncol 2003; 1: 47-51
    PubMedGoogle Scholar
  • 37 Loprinzi CL, Flynn PJ, Carpenter LA et al. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005; 8: 924-930
    CrossrefPubMedGoogle Scholar
  • 38 Kalay AE, Demir B, Haberal A et al. Efficacy of citalopram on climacteric symptoms. Menopause 2007; 14: 223-229
    CrossrefPubMedGoogle Scholar
  • 39 Jin Y, Desta Z, Stearns V et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 2005; 97: 30-39
    CrossrefPubMedGoogle Scholar
  • 40 Loprinzi L, Barton DL, Sloan JA et al. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002; 77: 1159-1163
    CrossrefPubMedGoogle Scholar
  • 41 Guttuso jr. T, Kurlan R, McDermott MP et al. Gabapentinʼs effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003; 101: 337-345
    CrossrefPubMedGoogle Scholar
  • 42 Pandya KJ, Morrow GR, Roscoe JA et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005; 366: 818-824
    CrossrefPubMedGoogle Scholar
  • 43 Lavigne JE, Heckler C, Mathews JL et al. A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors. Breast Cancer Res Treat 2012; 136: 479-486
    CrossrefPubMedGoogle Scholar
  • 44 Guttuso jr. T. Effective and clinically meaningful non-hormonal hot flash therapies. Maturitas 2012; 72: 6-12
    CrossrefPubMedGoogle Scholar
  • 45 Nelson HD, Vesco KK, Haney E et al. Nonhormonal therapies for menopausal hot flashes. Systematic review and meta-analysis. JAMA 2006; 295: 2057-2071
    CrossrefPubMedGoogle Scholar
  • 46 Mueck AO, Rabe T, Kiesel L. Hormonersatztherapie bei Patientinnen nach Mammakarzinom. J Reproduktionsmed Endokrinol 2006; 3: 145-154
    PubMedGoogle Scholar
  • 47 Baumelou A, Liu B, Wang XY et al. Perspectives in clinical research of acupuncture on menopausal symptoms. Chin J Integr Med 2011; 17: 893-897
    CrossrefPubMedGoogle Scholar